UK Government. Writing about ethnicity London: Crown; 2021 [Available from: https://www.ethnicity-facts-figures.service.gov.uk/style-guide/writing-about-ethnicity.
Harris C. Ethnic Minorities Maryland Scholastic; 2021 [Available from: https://www.scholastic.com/teachers/articles/teaching-content/ethnic-minorities/.
Glied S. Strategy drives implementation: COVID vaccination in Israel. Isr J Health Policy Res. 2021:10;9. https://doi.org/10.1186/s13584-021-00445-1.
Green MS, Abdullah R, Vered S, et al. A study of ethnic, gender and educational differences in attitudes toward COVID-19 vaccines in Israel – implications for vaccination implementation policies. Isr J Health Policy Res. 2021;10:26. https://doi.org/10.1186/s13584-021-00458-w.
Rosen B, Waitzberg R, Israeli A. Israel’s rapid rollout of vaccinations for COVID-19. Isr J Health Policy Res. 2021;10:6. https://doi.org/10.1186/s13584-021-00440-6.
Rosen, B., Dine, S., & Davidovitch, N. (2021). Lessons in COVID-19 vaccination from Israel. [available from: https://www.healthaffairs.org/do/10.1377/hblog20210315.476220/full/.
Caspi G, Dayan A, Eshal Y, Liverant-Taub S, Twig G, Shalit U, et al. Socioeconomic Disparities and COVID-19 Vaccination Acceptance: Experience from Israel. medRxiv. 2021;2021:01.28.21250716.
The OpenSAFELY Collaborative, MacKenna B, Curtis HJ, ea MCE. Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY.b2021. medRxiv OpenSAFELYb2021. 2021;01(25):2125035.
NHS England. COVID-19 Statistics. Leeds: NHSE 2021 [Available from: https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/.
Royal College of General Practitioners. GPs call for high-profile campaign backed by faith leaders and prominent figures from BAME communities to increase COVID-19 vaccine uptake. London: Royal College of General Practitioners; 2021. [Available from: https://www.rcgp.org.uk/about-us/news/2021/february/gps-call-for-high-profile-campaign-backed-by-faith-leaders.aspx.
The Royal Society and The British Academy. COVID-19 vaccine deployment: Behaviour, ethics, misinformation and policy strategies (21st October 2020). London: The Royal Society and The British Academy; 2020. [Available from: https://royalsociety.org/-/media/policy/projects/set-c/set-c-vaccine-deployment.pdf.
Royal Society for Public Health. New poll finds BAME groups less likely to want COVID vaccine (16 December 20). London: RSPH; 2020. [Available from: https://www.rsph.org.uk/about-us/news/new-poll-finds-bame-groups-less-likely-to-want-covid-vaccine.html.
Health Service Journal. Exclusive: Fewer black and Filipino NHS staff vaccinated amid 'hesitancy' concern. London: HSJ; 2021. [Available from: https://www.hsj.co.uk/acute-care/exclusive-fewer-black-and-filipino-nhs-staff-vaccinated-amid-hesitancy-concern/7029397.article.
Scientific Advisory Group for Emergencies (Ethnicity subgroup). Factors influencing COVID-19 vaccine uptake among minority ethnic groups. London: SAGE; 2020. [Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/952716/s0979-factors-influencing-vaccine-uptake-minority-ethnic-groups.pdf.
Scientific Advisory Group for Emergencies. LSHTM, UCL and Bristol: Extremely high SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK, 1 February 2021. London: SAGE; 2021. [Available from: https://www.gov.uk/government/publications/lshtm-ucl-and-bristol-extremely-high-sars-cov-2-seroprevalence-in-a-strictly-orthodox-jewish-community-in-the-uk-1-february-2021.
Fadnes LT, Jackson D, Engebretsen IMS, Zembe W, Sanders D, Sommerfelt H, et al. Vaccination coverage and timeliness in three south African areas: a prospective study. BMC Public Health. 2011;11(1):404. https://doi.org/10.1186/1471-2458-11-404.
Office for National Statistics. Coronavirus and the social impacts on Great Britain: 29 January 2021. London: Office for National Statistics; 2021. [Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/bulletins/coronavirusandthesocialimpactsongreatbritain/29january2021#attitudes-to-covid-19-vaccination-by-different-sub-groups-of-the-population.
Painter E, EN U, A P, Hughes MM, Zell ER, Moulia DL, et al. Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program - United States, December 14, 2020-January 14, 2021. MMWR. 2021;70(5):174–7.
Kaiser Family Foundation (KFF). KFF COVID-19 Vaccine Monitor - An ongoing research project tracking the public's attitudes and experiences with COVID-19 vaccinations. New York: Kaiser Family Foundation (KFF); 2021. [Available from: https://www.kff.org/coronavirus-covid-19/dashboard/kff-covid-19-vaccine-monitor-dashboard/?utm_source=web&utm_medium=trending&utm_campaign=COVID-19-vaccine-monitor.
Joint Committee on Vaccination and Immunisation (JCVI). Independent report; Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI, 30 December 2020. London: Joint Committee on Vaccination and Immunisation (JCVI); 2021. [Available from: https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020.
Joint Committee on Vaccination and Immunisation. Independent report - Annex A: COVID-19 vaccine and health inequalities: considerations for prioritisation and implementation. London: JCVI; 2021. [Available from: https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/annex-a-covid-19-vaccine-and-health-inequalities-considerations-for-prioritisation-and-implementation.
Department of Health and Social Care. Letter from the Health and Social Care Secretary to the JCVI: 11 March 2021. London: DHSC; 2021. [Available from: https://www.gov.uk/government/publications/letter-from-the-health-and-social-care-secretary-on-covid-19-vaccination-phase-1-advice/letter-from-the-health-and-social-care-secretary-to-the-jcvi-11-march-2021.
Sekalala S, Perehudoff K, Parker M, Forman L, Rawson B, Smith M. An intersectional human rights approach to prioritising access to COVID-19 vaccines. BMJ Glob Health. 2021;6(2):e004462. https://doi.org/10.1136/bmjgh-2020-004462.
European Centre for Disease Prevention and Control. Overview of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA and the UK. Stockholm: ECDC; 2020. [Available from: https://www.ecdc.europa.eu/en/publications-data/overview-current-eu-eea-uk-plans-covid-19-vaccines.
World Health Organization. WHO SAGE Roadmap for prioritising uses of COVID-19 vaccines in the context of limited supply. New York: WHO; 2020. [Available from: https://www.who.int/docs/default-source/immunization/sage/covid/sage-prioritization-roadmap-covid19-vaccines.pdf?Status=Temp&sfvrsn=bf227443_2.
The Association of Reproductive and Clinical Scientists and the British Fertility Society. COVID-19 vaccines and fertility. London: ARCS-BFS; 2021. [Available from: https://www.arcscientists.org/wp-content/uploads/2021/02/Covid19-Vaccines-FAQ-1_3.pdf.
Human Fertilisation and Embryology Authority. Coronavirus (COVID-19) guidance for patients. London: HFEA; 2021. Available from: https://www.hfea.gov.uk/treatments/covid-19-and-fertility-treatment/coronavirus-covid-19-guidance-for-patients/.
Royal College of Obstetricians and Gynaecologists and the Royal College of Midwives. The RCOG and the RCM respond to misinformation around Covid-19 vaccine and fertility; News 19 January 2021. London: RCOG; 2021. [Available from: https://www.rcog.org.uk/en/news/RCOG-and-RCM-respond-to-misinformation-around-Covid-19-vaccine-and-fertility/.
British Islamic Medical Association. COVID-19 Vaccine Hub -Your one stop shop on debunking myths surrounding the COVID 19 Vaccine! London: BIMA; 2021. [Available from: https://britishima.org/operation-vaccination/hub/.
Global Advisory Committee on Vaccine Safety. WHO COVID-19 vaccines risk communication plan. New York: World Health Organization; 2020. [Available from: https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/topics/covid-19.
Klimiuk K, Czoska A, Biernacka K, Balwicki Ł. Vaccine misinformation on social media – topic-based content and sentiment analysis of polish vaccine-deniers' comments on Facebook. Hum Vaccines Immunotherapeutics. 2021:1–10. https://doi.org/10.1080/21645515.2020.1850072.
Thiagarajan K. Covid-19: India is at Centre of global vaccine manufacturing, but opacity threatens public trust. BMJ. 2021;372:n196.
Cohen J. Russia's claim of a successful COVID-19 vaccine doesn't pass the 'smell test', critics say. London: Science; 2020. [Available from: https://doi.org/10.1126/science.abf6791.
Bucci E, Andreev K, Björkman A, Calogero RA, Carafoli E, Carninci P, et al. Safety and efficacy of the Russian COVID-19 vaccine: more information needed. Lancet. 2020;396(10256):e53. https://doi.org/10.1016/S0140-6736(20)31960-7.
Jones I, Roy P. Sputnik V COVID-19 vaccine candidate appears safe and effective. Lancet. 2021;397(10275):642–3. https://doi.org/10.1016/S0140-6736(21)00191-4.
Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021:21(5)637–46. https://doi.org/10.1016/S1473-3099(20)30942-7.
Anonymous. Update to living systematic review on covid-19 in pregnancy. BMJ. 2021;372:n615.
Pushparajah D, Jimenez S, Wong S, Alattas H, Nafissi N, Slavcev RA. Advances in gene-based vaccine platforms to address the COVID-19 pandemic. Adv Drug Deliv Rev. 2021;170:113–41. https://doi.org/10.1016/j.addr.2021.01.003.
Do H. Communicating about risks to public health: pointers to good practice. London: DOH; 1997.
Bennett P, Calman K. Risk communication and public health. Oxford: Oxford University Press; 1999.
UK Government. Vaccines Taskforce (VTF): 2020 achievements and future strategy London: UKVTF [Available from: https://www.gov.uk/government/publications/uk-government-vaccines-taskforce-vtf-2020-achievements-and-future-strategy.
UK Government. Race Disparities Unit. Second quarterly report on progress to address COVID-19 health inequalities (01.03.2021) London: Cabinet Office; 2021 [Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/967856/Second_Covid_Disparities_Report_Final_01-03-20__1_.pdf.
Medicines and Healthcare Products Regulatory Agency. Summary of the Public Assessment Report for Pfizer/BioNTech COVID-19 vaccine. London: MRHA; 2020. [Available from: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/summary-public-assessment-report-for-pfizerbiontech-covid-19-vaccine.
European Medicines Agency. EMA recommends first COVID-19 vaccine for authorisation in the EU: EMA; 2020. [Available from: https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu.
European Medicines Agency. Fast-track procedures for treatments and vaccines for COVID-19 (infographic). London: EMA; 2020. [Available from: https://www.ema.europa.eu/en/documents/leaflet/infographic-fast-track-procedures-treatments-vaccines-covid-19_en.pdf.
US Food and Drug Administration. The Path for a COVID-19 Vaccine from Research to Emergency Use Authorization (infographic). Washington DC: FDA; 2020. [Available from: https://www.fda.gov/media/143890/download.
World Health Organisation. Emergency Use Listing Procedure Version 13 December 2020. Geneva: WHO; 2020. [Available from: https://www.who.int/docs/default-source/medicines/eulprocedure.pdf?sfvrsn=55fe3ab8_7.
Coalition for Epidemic Preparedness Innovations. A leap forward in vaccine technology. London: CEPI; 2021. [Available from: https://cepi.net/news_cepi/a-leap-forward-in-vaccine-technology-2/.
Smith MJ, Ujewe S, Katz R, Upshur REG. Emergency use authorisation for COVID-19 vaccines: lessons from Ebola. Lancet. 2020;396(10264):1707–9. https://doi.org/10.1016/S0140-6736(20)32337-0.
Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–34. https://doi.org/10.1016/S0140-6736(21)00306-8.
NHS England. Vaccination sites (COVID-19): NHSE; 2021 [Available from: https://www.england.nhs.uk/coronavirus/publication/vaccination-sites/.
Ndugga N, Artiga S, Pham O. How are States Addressing Racial Equity in COVID-19 Vaccine Efforts? New York: Kaiser Family Foundation; 2021. [Available from: https://www.kff.org/racial-equity-and-health-policy/issue-brief/how-are-states-addressing-racial-equity-in-covid-19-vaccine-efforts/.
Razai MS, Osama T, McKechnie DGJ, Majeed A. Covid-19 vaccine hesitancy among ethnic minority groups. BMJ. 2021;372:n513.
Public Health England. NHS Staff Comms Toolkit. PHE. [Available from: https://coronavirusresources.phe.gov.uk/covid-19-vaccine/resources/nhs-staff-comms-toolkit/.
NHS Race & Health Observatory. Maximising the uptake of COVID-19 vaccine for ethic minority people (with infographic): NHS Confederation; 2021 [Available from: https://www.nhsconfed.org/networks/nhs-race-and-health-observatory/vaccine-uptake.
Kelley B. Developing therapeutic monoclonal antibodies at pandemic pace. Nat Biotechnol. 2020;38(5):540–5. https://doi.org/10.1038/s41587-020-0512-5.
Marist Polls. NPR/PBS NewsHour/Marist Poll of 1,227 National Adults (March 3rd through March 8th 2021). London: NPR and PBS NewsHour; 2021. [Available from: http://maristpoll.marist.edu/wp-content/uploads/2021/03/NPR_PBS-NewsHour_Marist-Poll_USA-NOS-and-Tables_202103091124.pdf.
Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;S2468–2667(21):00012–8.
Biddle N, Edwards B, Gray M, Sollis K. Change in vaccine willingness in Australia: August 2020 to January 2021 Sydney. Australia: ANU Centre for Social Research and Methods; 2021. [Available from: https://www.medrxiv.org/content/10.1101/2021.02.17.21251957v1.full.pdf
Selvarajah S, Deivanayagam TA, Lasco G, Scafe S, White A, Zembe-Mkabile W, et al. Categorisation and Minoritisation. BMJ Glob Health. 2020;5(12):e004508. https://doi.org/10.1136/bmjgh-2020-004508.
Wilf-Miron R, Myers V, Saban M. Incentivizing Vaccination Uptake: The "Green Pass" Proposal in Israel. JAMA. Published online March 15, 2021. [Available from: https://doi.org/10.1001/jama.2021.4300.
Crowcroft NS, Klein NP. A framework for research on vaccine effectiveness. Vaccine. 2018;36(48):7286–93.62. https://doi.org/10.1016/j.vaccine.2018.04.016.
Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. NEJM. 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2104840.
Royal College of General Practitioners. Increasing uptake of vaccinations for vulnerable groups of patients. RCGP. [Available from: https://elearning.rcgp.org.uk/mod/page/view.php?id=11930.
McKee M, Rajan S. What can we learn from Israel’s rapid roll out of COVID 19 vaccination?. Isr J Health Policy Res. 2021:10;5. https://doi.org/10.1186/s13584-021-00441-5.
IPSOS MORI. News 6th April 2021 - Vaccine confidence grows month-on-month in latest Ipsos MORI KnowledgePanel poll. [Available from: https://www.ipsos.com/ipsos-mori/en-uk/vaccine-confidence-grows-month-month-latest-ipsos-mori-knowledgepanel-poll.